Lipocalin 2 is present in the EAE brain and is modulated by natalizumab

Multiple sclerosis (MS) is a demyelinating disease that causes major neurological disability in young adults. A definitive diagnosis at the time of the first episode is still lacking, but since early treatment leads to better prognosis, the search for early biomarkers is needed. Here we characterize...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Marques, Fernanda, Mesquita, Sandro D., Sousa, João C., Coppola, Giovanni, Gao, Fuying, Geschwind, Daniel H., Columba-Cabezas, Sandra, Aloisi, Francesca, Degn, Matilda, Cerqueira, João J., Sousa, Nuno, Correia-Neves, Margarida, Palha, Joana A.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2012
Assuntos:
Neuroscience
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414908/
https://ncbi.nlm.nih.gov/pubmed/22907989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2012.00033
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares